demonstrated that CYP7A1 polymorphisms influence faecal bile acid concentrations and serve as risk factors for colorectal adenoma development, with UDCA's preventive efficacy modulated by genetic variation in CYP7A1 [83]. This evidence concerns the gene CYP7A1 and colorectal adenoma.